Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Esophageal Neoplasms"" wg kryterium: Temat


Tytuł:
Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females.
Autorzy:
Fukuhara M; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Urabe Y; Gastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Nakahara H; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ishikawa A; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ishibashi K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Konishi H; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Mizuno J; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tanaka H; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Tsuboi A; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yamashita K; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hiyama Y; Department of Clinical Research Center, Hiroshima University Hospital, Hiroshima, Japan.
Takigawa H; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Kotachi T; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yuge R; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hayes CN; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Oka S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7078.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Humans ; Female ; Non-Smokers ; Genomics
Czasopismo naukowe
Tytuł:
Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study.
Autorzy:
Zheng H; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China.
Zhang H; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China.
Zhu Y; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China.
Wei X; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China.
Liu S; Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China. .
Ren W; The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, 210008, China. .
Pokaż więcej
Źródło:
BMC medical imaging [BMC Med Imaging] 2024 Jan 12; Vol. 24 (1), pp. 18. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/therapy
Humans ; Prognosis ; Chemoradiotherapy/methods ; Biomarkers ; Magnetic Resonance Imaging/methods ; Hypoxia/drug therapy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Enabling large-scale screening of Barrett's esophagus using weakly supervised deep learning in histopathology.
Autorzy:
Bouzid K; Microsoft Health Futures, Cambridge, UK.
Sharma H; Microsoft Health Futures, Cambridge, UK.
Killcoyne S; Cyted Ltd, Cambridge, UK.
Castro DC; Microsoft Health Futures, Cambridge, UK.
Schwaighofer A; Microsoft Health Futures, Cambridge, UK.
Ilse M; Microsoft Health Futures, Cambridge, UK.
Salvatelli V; Microsoft Health Futures, Cambridge, UK.
Oktay O; Microsoft Health Futures, Cambridge, UK.
Murthy S; Cyted Ltd, Cambridge, UK.
Bordeaux L; Cyted Ltd, Cambridge, UK.
Moore L; Department of Histopathology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
O'Donovan M; Cyted Ltd, Cambridge, UK.; Department of Histopathology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK.
Thieme A; Microsoft Health Futures, Cambridge, UK.
Nori A; Microsoft Health Futures, Cambridge, UK.
Gehrung M; Cyted Ltd, Cambridge, UK. .
Alvarez-Valle J; Microsoft Health Futures, Cambridge, UK. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Mar 11; Vol. 15 (1), pp. 2026. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Barrett Esophagus*/diagnosis
Barrett Esophagus*/pathology
Deep Learning*
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/pathology
Adenocarcinoma*/diagnosis
Adenocarcinoma*/pathology
Humans ; Metaplasia
Czasopismo naukowe
Tytuł:
Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer.
Autorzy:
Xu X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Sun Z; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu Q; Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of Gastroenterology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen L; Department of Gastroenterology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang C; Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lin H; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hu B; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rong L; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen H; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao X; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bai YR; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Ye Q; Department of Thoracic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Ma X; Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China .
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 07; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/drug therapy
Thrombocytopenia*
Lymphopenia*
Antibodies, Monoclonal, Humanized*
Humans ; Cisplatin/therapeutic use ; Neoadjuvant Therapy ; Treatment Outcome ; Neoplasm Recurrence, Local ; Paclitaxel ; HLA-DR Antigens ; Epithelial Cells/pathology
Czasopismo naukowe
Tytuł:
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
Autorzy:
Fan C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Sun Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Ye K; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jiang Q; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
He C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Nie X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Tan B; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhang Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Feng Z; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Yang C; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Lu Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Chen X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu F; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zheng X; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wang J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Wu S; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Chen G; Xinyang Hospital Affiliated to Zhengzhou University & Xinyang Central Hospital, Xinyang, 464000, China.
Zhang Y; Anyang Cancer Hospital, Anyang, 455000, China.
Jin L; Anyang Cancer Hospital, Anyang, 455000, China.
Ge H; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 321. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/radiotherapy
Humans ; Consolidation Chemotherapy ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.
Autorzy:
Chen J; Department of Oncology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Lu J; The Health Supervision Institute of Suzhou, Suzhou, Jiangsu, China.
Chen Z; Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Liu Z; Department of Oncology, Suqian Hospital Affiliated to Xuzhou Medical University, Suqian Hospital of Nanjing Drum Tower Hospital Group, Suqian, Jiangsu, China.
Sun Y; Department of Pathology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
He S; Department of Oncology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Mi Y; Department of Cardio-Thoracic Surgery, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Gao Y; Department of Gastroenterology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Shen D; Department of Oncology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Lin Q; Department of Oncology, Jiangyin People's Hospital, Jiangyin Clinical College of Xuzhou Medical University, Jiangyin Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Pokaż więcej
Źródło:
The journal of gene medicine [J Gene Med] 2024 Mar; Vol. 26 (3), pp. e3667.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/immunology
Esophageal Neoplasms*/metabolism
Esophageal Squamous Cell Carcinoma*/immunology
Esophageal Squamous Cell Carcinoma*/metabolism
Serine Peptidase Inhibitor Kazal-Type 5*/metabolism
Humans ; HEK293 Cells ; Lipopolysaccharides ; NF-kappa B/metabolism ; RNA, Messenger/metabolism ; Toll-Like Receptor 4/metabolism
Czasopismo naukowe
Tytuł:
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma.
Autorzy:
Liu XS; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.; Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhang Y; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Liu ZY; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Gao Y; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Yuan LL; Department of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zeng DB; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Tan F; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Wan HB; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Pei ZJ; Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of liver cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.; Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Mar; Vol. 28 (6), pp. e18195.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/genetics
Methyltransferases*/genetics
Humans ; Biomarkers ; Glycolysis/genetics ; Lactic Acid ; RNA, Competitive Endogenous
Czasopismo naukowe
Tytuł:
PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Autorzy:
Chang Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Jia Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Gao M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Song L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Zhang W; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Zhao R; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Yu D; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Liu X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Li J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China.
Qin Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China. .; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, 450052, P.R. China. .
Pokaż więcej
Źródło:
Biology direct [Biol Direct] 2024 Mar 01; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Squamous Cell Carcinoma*/pathology
Vascular Endothelial Growth Factor A*/genetics
Vascular Endothelial Growth Factor A*/metabolism
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Proteins c-akt/genetics ; RNA-Binding Proteins/genetics ; Trans-Activators/genetics
Czasopismo naukowe
Tytuł:
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab.
Autorzy:
Chen B; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Liu S; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Zhu Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Wang R; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Cheng X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Chen B; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Dragomir MP; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zhang Y; Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, PR China.
Hu Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Liu M; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
Li Q; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China. .; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China. .
Yang H; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China. .; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China. .
Xi M; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Guangzhou, Guangdong, PR China. .; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Mar 01; Vol. 15 (1), pp. 1919. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/therapy
Antibodies, Monoclonal, Humanized*
Humans ; Quality of Life ; Chemoradiotherapy
Czasopismo naukowe
Tytuł:
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
Autorzy:
Chen J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China; Soochow University Cancer Institute, Suzhou 215000, China. Electronic address: cj_.
Zhao D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Zhang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Xiao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wu Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China.
Zhan Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University International Cancer Institute, Peking University, Beijing 100191, China; Research Unit of Molecular Cancer Research, Chinese Academy of Medical Sciences, Beijing, China; Soochow University Cancer Institute, Suzhou 215000, China; Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518107, China. Electronic address: .
Pokaż więcej
Źródło:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2024 Mar; Vol. 73, pp. 101055. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Humans ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Diacylglycerol Kinase/genetics ; Diacylglycerol Kinase/pharmacology ; Tumor-Associated Macrophages ; NADPH Oxidase 4/genetics ; Reactive Oxygen Species ; RNA, Small Interfering/genetics ; Cell Proliferation ; Chemokines/pharmacology ; Chemokines/therapeutic use ; Cell Line, Tumor ; Chemokine CCL22/pharmacology ; Chemokine CCL22/therapeutic use
Czasopismo naukowe
Tytuł:
Development and evaluation of a program based on a generative pre-trained transformer model from a public natural language processing platform for efficiency enhancement in post-procedural quality control of esophageal endoscopic submucosal dissection.
Autorzy:
Ma H; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China.; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China.
Ma X; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China.; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China.
Yang C; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China.; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China.
Niu Q; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China.; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China.
Gao T; Endoscopy Center of Binzhou Medical University Hospital, Binzhou, Shandong, China.
Liu C; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China. .; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China. .; Endoscopy Center of Binzhou Medical University Hospital, Binzhou, Shandong, China. .
Chen Y; Department of Gastroenterology and Hepatology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, China. .; Digestive Disease Research Institute of Binzhou Medical University Hospital, Binzhou, Shandong, China. .; Endoscopy Center of Binzhou Medical University Hospital, Binzhou, Shandong, China. .
Pokaż więcej
Źródło:
Surgical endoscopy [Surg Endosc] 2024 Mar; Vol. 38 (3), pp. 1264-1272. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Endoscopic Mucosal Resection*/methods
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/pathology
Humans ; Retrospective Studies ; Natural Language Processing ; Quality Control
Czasopismo naukowe
Tytuł:
Robot-assisted transcervical esophagectomy with a bilateral cervical approach for thoracic esophagectomy.
Autorzy:
Fujita T; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. .
Sato K; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Fujiwara N; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Kajiyama D; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Shigeno T; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Otomo M; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Daiko H; Division of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
Surgical endoscopy [Surg Endosc] 2024 Mar; Vol. 38 (3), pp. 1617-1625. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Robotics*
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/complications
Humans ; Lymph Node Excision/methods ; Esophagectomy/methods ; Mediastinoscopy/adverse effects ; Mediastinoscopy/methods ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Postoperative Complications/surgery ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma.
Autorzy:
Chao L; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Liu J; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Chen Y; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Fan Y; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Guo S; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Zhang S; Department of Thoracic Surgery, Shanxi Cancer Hospital, Taiyuan, PR China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 622-629. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*
Humans ; Carboplatin/therapeutic use ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use ; Retrospective Studies ; Induction Chemotherapy ; Neoadjuvant Therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Albumins/therapeutic use
Czasopismo naukowe
Tytuł:
Zinc deficiency drives ferroptosis resistance by lactate production in esophageal squamous cell carcinoma.
Autorzy:
Yang P; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Li H; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Sun M; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Guo X; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Liao Y; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Hu M; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Ye P; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.
Liu R; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China. Electronic address: .
Pokaż więcej
Źródło:
Free radical biology & medicine [Free Radic Biol Med] 2024 Mar; Vol. 213, pp. 512-522. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Carcinoma, Squamous Cell*/metabolism
Ferroptosis*/genetics
Malnutrition*
Humans ; Lactic Acid ; Case-Control Studies ; Zinc/metabolism ; Cell Proliferation ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
DUSP4 maintains the survival and LSD1 protein stability in esophageal squamous cell carcinoma cells by inhibiting JNK signaling-dependent autophagy.
Autorzy:
Liu X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, Jiangxi, China.; Gannan Branch of National Clinical Research Center for Geriatrics Ganzhou 341000, Jiangxi, China.
Ye Z; Department of Digestive, The 900Th Hospital of Joint Logistic Support Force, PLA, Fuzhou, 350001, Fujian, China.
Rao D; Department of Thoracic Surgery, First Affiliated Hospital of Gannan Medical University, No. 3, Outangli, Xingannan Road, Zhanggong District, Ganzhou, 341000, Jiangxi, China.
Chen Q; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, China. .
Zhang Z; Department of Thoracic Surgery, First Affiliated Hospital of Gannan Medical University, No. 3, Outangli, Xingannan Road, Zhanggong District, Ganzhou, 341000, Jiangxi, China. .; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, China. .
Pokaż więcej
Źródło:
In vitro cellular & developmental biology. Animal [In Vitro Cell Dev Biol Anim] 2024 Mar; Vol. 60 (2), pp. 115-122. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/pathology
Animals ; Anisomycin ; Beclin-1/genetics ; Cell Line, Tumor ; Autophagy/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Carcinogenesis/genetics ; Carcinogenesis/pathology ; Protein Stability ; Sirolimus/pharmacology ; Histone Demethylases/genetics ; Histone Demethylases/metabolism ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Research on triamcinolone-loaded thermosensitive chitosan hydrogels for preventing esophageal stricture induced by endoscopic submucosal dissection.
Autorzy:
Wang Y; North Sichuan Medical College, Nanchong 637000, Sichuan, China.
Su Y; Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China; Department of Gastroenterology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
Zhu Y; North Sichuan Medical College, Nanchong 637000, Sichuan, China.
Ni P; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan 610064, China; Sichuan Testing Centre for Biomaterials and Medical Devices, Chengdu, Sichuan 610064, China.
Yu T; North Sichuan Medical College, Nanchong 637000, Sichuan, China.
Yuan T; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan 610064, China; Sichuan Testing Centre for Biomaterials and Medical Devices, Chengdu, Sichuan 610064, China.
Sun X; Department of Gastroenterology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
Shan J; Department of Gastroenterology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 261 (Pt 1), pp. 129679. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Stenosis*/etiology
Esophageal Stenosis*/prevention & control
Chitosan*/pharmacology
Endoscopic Mucosal Resection*/adverse effects
Endoscopic Mucosal Resection*/methods
Esophageal Neoplasms*/pathology
Esophageal Neoplasms*/surgery
Humans ; Animals ; Rats ; Triamcinolone ; Hydrogels
Czasopismo naukowe
Tytuł:
Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway.
Autorzy:
Liang H; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Che W; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Peng F; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Chen H; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Xie X; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Wu B; Department of thoracic surgery, Gaozhou people's Hospital, Gaozhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 538-549. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Matrix Attachment Region Binding Proteins*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Diterpenes*
Phenanthrenes*
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Signal Transduction ; Epoxy Compounds
Czasopismo naukowe
Tytuł:
Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer.
Autorzy:
van der Zijden CJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: .
van der Sluis PC; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Nuyttens JJME; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Toxopeus ELA; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Valkema R; Department of Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Beerepoot LV; Department of Medical Oncology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.
van Halteren HK; Department of Medical Oncology, Admiraal de Ruyter Hospital, Goes, the Netherlands.
Lagarde SM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Wijnhoven BPL; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Mar; Vol. 50 (3), pp. 107968. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/drug therapy
Adenocarcinoma*/surgery
Adenocarcinoma*/drug therapy
Humans ; Induction Chemotherapy/methods ; Esophagectomy/methods ; Neoadjuvant Therapy/methods ; Survival Rate ; Retrospective Studies ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Pseudo-medical image-guided technology based on 'CBCT-only' mode in esophageal cancer radiotherapy.
Autorzy:
Sun H; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yang Z; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhu J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
Li J; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Gong J; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Chen L; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Wang Z; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yin Y; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ren G; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. Electronic address: .
Cai J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. Electronic address: .
Zhao L; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Electronic address: .
Pokaż więcej
Źródło:
Computer methods and programs in biomedicine [Comput Methods Programs Biomed] 2024 Mar; Vol. 245, pp. 108007. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Spiral Cone-Beam Computed Tomography*
Radiotherapy, Image-Guided*/methods
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/radiotherapy
Neuroectodermal Tumors, Primitive*
Humans ; Radiotherapy Planning, Computer-Assisted/methods ; Cone-Beam Computed Tomography/methods ; Image Processing, Computer-Assisted/methods
Czasopismo naukowe
Tytuł:
Endoscopic resection of giant esophageal subepithelial lesions: experience from a large tertiary center.
Autorzy:
Xiang AY; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang KH; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Su W; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Tan T; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Qu YF; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Li XQ; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang Y; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Cai MY; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Li QL; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang YQ; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.
Hu H; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: .
Zhou PH; Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło:
Gastrointestinal endoscopy [Gastrointest Endosc] 2024 Mar; Vol. 99 (3), pp. 358-370.e11. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/surgery
Esophageal Neoplasms*/pathology
Endoscopic Mucosal Resection*/methods
Humans ; Endoscopy ; Treatment Outcome ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies